Articles Tagged With:
-
Predicting Which Patients with Non-alcoholic Fatty Liver Disease Will Progress
Certain non-alcoholic fatty liver disease patients have a progressive type called non-alcoholic steatohepatitis, which itself may progress to cirrhosis and hepatocellular carcinoma.
-
Preventing Recurrence of Depression: Cognitive Therapy or Medication?
Over a 24-month interval, slightly fewer than half of the subjects experienced relapse, with no significant difference demonstrable between mindfulness-based cognitive therapy and pharmacotherapy.
-
How Long Should We Treat with Warfarin for Symptomatic Venous Thromboembolism?
Long-term anticoagulation was associated with about an 80% reduction in recurrent venous thromboembolic events compared to short-term anticoagulation.
-
Stroke Accelerates Long-term Process of Cognitive Decline
Following an acute stroke, executive function declined significantly — more steeply than in controls; encouragingly, the capacity for new learning post-stroke did not decline.
-
Extending the Window of Anticoagulation After Pulmonary Embolus
After the initial 6-month treatment of pulmonary embolus, extended anticoagulation of up to 18 months dramatically reduces risk of recurrence at the expense of more episodes of major bleeding.
-
Hospital Consult - August 2015
-
Get CDC fact sheet on shigellosis
The Centers for Disease Control and Prevention have a patient information sheet on shigellosis. Shigellosis is a common diarrheal disease caused by a group of bacteria called Shigella.
-
Data suggest genital screening misses many STI cases in women
Data from a recent study that looked at more than 10,000 people who attended a Baltimore public health clinic indicate the occurrence of gonorrhea or chlamydia in extragenital areas such as the throat or rectum is significant in women, particularly younger women.
-
Time to update your clinical practice: 2015 STD Treatment Guidelines available
The Centers for Disease Control and Prevention has released the 2015 STD Treatment Guidelines.
-
Liletta IUD available in the United States
The LILETTA intrauterine device is for sale in the United States. The device was launched through partners Medicines360, a San Francisco-based nonprofit pharmaceutical company, and Actavis, a Dublin, Ireland-based pharmaceutical company.